First valved tube implanted

August 1, 2017

The TEH-TUBE consortium has reached a significant milestone in its objectives to create a bioresorbable valved tube for the potential treatment of RVOT. The first implantation of our novel bioresorbable valved tube has been undertaken in France. The implanted valved tube is functioning and we are confident that this is an important step towards achieving our objectives. 





Please reload

The TEH-TUBE project has been partially funded by the European Union Seventh Framework Programme (FP7)

© Copyright TEH-TUBE consortium 2017